Improving diagnosis and care for HIV-infected patients with Kaposi Sarcoma in East Africa
Project 2: Rapid Case Ascertainment as a Tool for Epidemiologic Investigation and Efficient Linkage to Care in HIV-infected Patients Diagnosed with Kaposi Sarcoma in East Africa
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-10866372
This study is working to improve how we find and treat Kaposi Sarcoma in people with HIV in East Africa, helping them get the care they need more quickly and understand what makes the disease worse, all while partnering with local healthcare providers in Uganda and Kenya.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-10866372 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the diagnosis and treatment of Kaposi Sarcoma (KS) in HIV-infected patients in East Africa. It aims to rapidly identify individuals recently diagnosed with KS and assess their health status to facilitate timely access to cancer care. By implementing rapid case ascertainment, the study seeks to understand the factors contributing to advanced disease stages and poor survival rates, while also evaluating the effectiveness of interventions that guide patients to appropriate treatment. The research is conducted in collaboration with healthcare providers in Uganda and Kenya to ensure culturally relevant and effective strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are HIV-infected individuals diagnosed with Kaposi Sarcoma in East Africa.
Not a fit: Patients who are not HIV-infected or do not have a diagnosis of Kaposi Sarcoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and quality of care for patients diagnosed with Kaposi Sarcoma.
How similar studies have performed: Previous research has shown promise in using rapid case ascertainment for improving cancer care, making this approach both innovative and grounded in emerging evidence.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BYAKWAGA, HELEN — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: BYAKWAGA, HELEN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: AIDS associated cancer, AIDS related cancer, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus